InvestorsHub Logo
Followers 220
Posts 16076
Boards Moderated 6
Alias Born 06/02/2007

Re: Zorch305 post# 7151

Monday, 05/30/2011 9:21:27 AM

Monday, May 30, 2011 9:21:27 AM

Post# of 7574
"The company already said it was a banking matter and should be taken care of by June 1st"

The company also said:

1) It was a global pharma company based in Boston

2) That Met4 would be launched in the US, Canada and the EU during 2011

3) That they had a research collaboration with INSA of France.

4) That they possessed an International R&D capability

5) That they would be purchased by Al-Dora/Al-Dorra/Al Durrah/Hail First Pharma by April 1.

6) That Hail First Pharma was a Middle Eastern- based company

7) That I was libelling them and they were going to take me to court

We now know that every one of those statements, and virtually every other claim ever made by Spencer Pharma "and" Al-Dora/Al-Dorra/Al Durrah/Hail First Pharma (for they are one and the same) is a lie.

For that reason, I suspect Herr Morgenstern is somewhat more reliable than "the company".

But I guess we'll know soon enough when all you Spencer Pharma shareholders get $1.10 in cash for each of your SPPH shares.

Except you won't of course.

Not ever, because, like it or not, it's obvious that technology that hasn't advanced beyond animal tests (by SPPH's own admission - I doubt it's even got that far, in reality) for sustained release forms of generic commodities metformin and ibuprofen isn't even worth a hundred thousand dollars, let alone $245 million.


"It is difficult to get a man to understand something, when his salary depends upon his not understanding it."

Upton Sinclair

"Nobody ever went broke underestimating the intelligence of the American public."

H. L. Mencken